A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. - Thom, George; Tian, Mei-Mei; Hatcher, Jon P; Rodrigo, Natalia; Burrell, Matthew; Gurrell, Ian; Vitalis, Timothy Z; Abraham, Thomas; Jefferies, Wilfred A; Webster, Carl I; Gabathuler, Reinhard (Journal of Cerebral Blood Flow & Metabolism, 2019)